| Impact of comorbidities on the mortality benefits of lung cancer screening: a post-hoc analysis of PLCO and NLST trials. |
39798695
|
Gendarme S, Irajizad E, Long JP, Fahrmann JF, Dennison JB, Ghasemi SM, Dou R, Volk RJ, Meza R, Toumazis I, Canoui-Poitrine F, Hanash SM, Ostrin EJ |
J Thorac Oncol |
2025 |
PLCO, NLST |
| Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals. |
39868889
|
Weiss J, Bernatz S, Johnson J, Thiriveedhi V, Mak RH, Fedorov A, Lu MT, Aerts HJWL |
J Intern Med |
2025 |
NLST |
| Fully automated coronary artery calcium score and risk categorization from chest CT using deep learning and multiorgan segmentation: A validation study from National Lung Screening Trial (NLST). |
39850777
|
Rathore S, Gautam A, Raghav P, Subramaniam V, Gupta V, Rathore M, Rathore A, Rathore S, Iyengar S |
Int J Cardiol Heart Vasc |
2025 |
NLST |
| A benchmark of deep learning approaches to predict lung cancer risk using national lung screening trial cohort. |
39799226
|
Jiang Y, Ebrahimpour L, Després P, Manem VS |
Sci Rep |
2025 |
NLST |
| OPPORTUNISTIC ASSESSMENT OF CARDIOVASCULAR RISK USING AI-DERIVED STRUCTURAL AORTIC AND CARDIAC PHENOTYPES FROM NON-CONTRAST CHEST COMPUTED TOMOGRAPHY. |
39974056
|
Oo DW, Sturniolo A, Jung M, Langenbach M, Foldyna B, Kiel DP, Aerts HJ, Natarajan P, Lu MT, Raghu VK |
medRxiv |
2025 |
NLST |
| Association of Epicardial Adipose Tissue Changes on Serial Chest CT Scans with Mortality: Insights from the National Lung Screening Trial. |
39964263
|
Langenbach IL, Hadzic I, Zeleznik R, Langenbach MC, Maintz D, Mayrhofer T, Lu MT, Aerts HJWL, Foldyna B |
Radiology |
2025 |
NLST |
| A generalized health index: automated thoracic CT-derived biomarkers predict life expectancy. |
39535867
|
Beeche C, Yu T, Wang J, Wilson D, Chen P, Duman E, Pu J |
Br J Radiol |
2025 |
NLST |
| Data augmented lung cancer prediction framework using the nested case control NLST cohort. |
40071099
|
Jiang Y, Manem VSK |
Front Oncol |
2025 |
NLST |
| Visual Emphysema as a Category Modifier in Lung-RADS: Secondary Analysis of National Lung Screening Trial. |
40049568
|
Jang S, Kim J, Lee S, Kim YW, Kim J, Lee KW, Lee CT |
J Am Coll Radiol |
2025 |
NLST |
| Positive Screens Are More Likely in a National Lung Cancer Screening Registry Than the National Lung Screening Trial. |
40023436
|
Tailor TD, Gutman R, An N, Hoffman RM, Chiles C, Carlos RC, Sicks JD, Gareen IF |
J Am Coll Radiol |
2025 |
NLST |
| AutoCOPD-A novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study. |
40242563
|
Lin F, Zhang Z, Wang J, Liang C, Xu J, Zeng X, Zeng Q, Chen H, Zhuang J, Ma Y, Ma Q, Shi R, Xu J, Li Y, Yuan L, Wei X, Wu L, Huang R, Xiao T, Liang W, Zheng J, He J, Liu Y, Liang Z, Zhong N, Lu W |
EClinicalMedicine |
2025 |
NLST |
| Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease. |
40236262
|
Behr CM, IJzerman MJ, Kip MMA, Groen HJM, Heuvelmans MA, van den Berge M, van der Harst P, Vonder M, Vliegenthart R, Koffijberg H |
JTO Clin Res Rep |
2025 |
NLST |
| Virtual lung screening trial (VLST): An in silico study inspired by the national lung screening trial for lung cancer detection. |
40209556
|
Tushar FI, Vancoillie L, McCabe C, Kavuri A, Dahal L, Harrawood B, Fryling M, Zarei M, Sotoudeh-Paima S, Ho FC, Ghosh D, Harowicz MR, Tailor TD, Luo S, Segars WP, Abadi E, Lafata KJ, Lo JY, Samei E |
Med Image Anal |
2025 |
NLST |
| Respiratory Function as a Prognostic Factor for Lung Cancer in Screening and General Populations. |
39589279
|
Murison KR, Warkentin MT, Khodayari Moez E, Brhane Y, Liu G, Hung RJ |
Ann Am Thorac Soc |
2025 |
NLST |
| Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence. |
40446891
|
Wu VS, Boutros C, Bassiri A, Jiang B, Sinopoli J, Tapias-Vargas L, Linden PA, Towe CW |
Ann Thorac Surg |
2025 |
NLST |
| The Effect of Clinical Factors on the Reversion of Cg05575921 Methylation in Smoking Cessation. |
40407421
|
Philibert R, Beach SRH, vanDellen MR, Mills JA, Long JD |
Epigenomes |
2025 |
NLST |
| A retrospective cohort study investigating factors affecting recommendation for continued low-dose computed tomography lung cancer screening in the national lung cancer screening trial. |
40398498
|
Buck B, Yates A, Bui J, McCoy A, Wisnieski L |
J Med Screen |
2025 |
NLST |
| Application of the joint clustering algorithm based on Gaussian kernels and differential privacy in lung cancer identification. |
40379735
|
Yanping H, Haixia Z, Minmin Y, Nan W, Miaomiao K, Mingming Z |
Sci Rep |
2025 |
NLST |
| Polygenic Risk Score Is Associated with Developing and Dying from Lung Cancer in the National Lung Screening Trial. |
40364136
|
Young RP, Scott RJ, Callender T, Duan F, Billings P, Aberle DR, Gamble GD |
J Clin Med |
2025 |
NLST |
| Evaluating the Non-Malignancy Rate in the National Lung Screening Trial: Addressing Surgical Misclassification. |
40350148
|
Caruso CR, Kim RY, Rendle KA, Vachani A |
Chest |
2025 |
NLST |
